Cite
HARVARD Citation
Kikuchi, E. et al. (2020). Cabozantinib as a choice for platinum-refractory metastatic urothelial cancer. Lancet oncology. 21 (8), pp. 1005-1006. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kikuchi, E. et al. (2020). Cabozantinib as a choice for platinum-refractory metastatic urothelial cancer. Lancet oncology. 21 (8), pp. 1005-1006. [Online].